We are live on ! Find out more
KIDS icon

OrthoPediatrics

56 hedge funds and large institutions have $137M invested in OrthoPediatrics in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 10

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

101% more capital invested

Capital invested by funds: $68M → $137M (+$68.9M)

17% more funds holding

Funds holding: 4856 (+8)

4.89% more ownership

Funds ownership: 35.36%40.24% (+4.9%)

Holders
56
Holders Change
+8
Holders Change %
+16.67%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
28
Reduced
10
Closed
6
Calls
Puts
Net Calls
Net Calls Change

KIDS Hedge Fund Activity: Q2 2018 in Review

56 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in OrthoPediatrics (KIDS) for Q2 2018, worth a combined $137M — up 101% from $68M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new KIDS positions and 6 closed out — a net gain of 8 holders — while 28 added to existing stakes and 10 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $3.53M. The largest seller was OrbiMed, cutting an estimated $6.15M.

  • 56 institutional investors held OrthoPediatrics (KIDS) as of Q2 2018, up from 48 in Q1 2018.
  • Funds reported $137M of OrthoPediatrics stock for Q2 2018, up 101% quarter-over-quarter.
  • 14 funds opened new OrthoPediatrics positions in Q2 2018 and 6 closed out, a net change of +8 holders.
  • The largest OrthoPediatrics buyer in Q2 2018 was Wasatch Advisors, an estimated $3.53M added.
  • The largest OrthoPediatrics seller in Q2 2018 was OrbiMed, an estimated $6.15M sold.

Based on aggregated 13F filings for Q2 2018.